O'Brien ETF 128 being used on a patient to identify peripheral neuropathy

Biomedix to offer a free O’Brien ETF128 tuning fork with PADnet purchases for Diabetes Awareness Month

In honor of Diabetes Awareness Month this November, Biomedix is inviting all healthcare professionals to optimize care for their diabetic patients through the earlier identification of related chronic complications such as Peripheral Artery Disease (PAD), and now Peripheral Neuropathy through a new partnership with O’Brien Medical. To build on our Read more…

Update: On-Demand Biomedix webinar on operationalizing PADnet in your practice

Join us for a webinar session to see how some successful PADnet® champions have operationally integrated PADnet vascular testing into their clinical workflow.During this roundtable-style webinar, we’ll review effective workflows for your practice to accelerate and simplify your use of PADnet. We’ll go over the patient experience before, during and Read more…

PADnet Xpress with laptop and screenshot

New published whitepaper establishes clinical accuracy of PADnet Xpress

Lower Extremity Review magazine published a whitepaper online highlighting a clinical study comparing the diagnostic results of PADnet Xpress with other established, gold-standard technologies used to perform physiologic studies to non-invasively detect peripheral artery disease (PAD). This whitepaper was authored by Sue Duval, PhD and Associate Professor of the University Read more…

60601-1-11-compliant

PADnet Xpress Passes Electrical Safety Certification for Home Use

Advances Platform as Technology of Choice for In-Home Wellness Assessments Today Biomedix announced it has successfully received an important electrical safety certification required for in-home health screenings. PADnet Xpress, the latest technology from Biomedix designed for peripheral artery disease (PAD) identification, has successfully passed IEC 60601-1-11 testing, confirming it is Read more…

Drug Test